These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 18617357

  • 1. In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells.
    Qin J, Yuan J, Li L, Liu H, Qin R, Qin W, Chen B, Wang H, Wu K.
    Biomed Pharmacother; 2009 Mar; 63(3):241-8. PubMed ID: 18617357
    [Abstract] [Full Text] [Related]

  • 2. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS, Liu DS, Dai CW, Li RJ.
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin.
    Zhao S, Cai J, Bian H, Gui L, Zhao F.
    Cancer Invest; 2009 Jul; 27(6):636-40. PubMed ID: 19387877
    [Abstract] [Full Text] [Related]

  • 5. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H, Choy H, Amorino GP, Kim JS, Cao Q, Hercules SK, DuBois RN.
    Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
    Zuo CH, Li ZR, Zhou X, Ouyang YZ, Zhou ZY, Zeng L.
    Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4670-9. PubMed ID: 15269139
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M, Tsuji S, Tsujii M, Irie T, Komori M, Kimura A, Nishida T, Kakiuchi Y, Kawai N, Murata H, Horimoto M, Sasaki Y, Hayashi N, Kawano S, Hori M.
    Cancer Res; 2003 Oct 15; 63(20):6726-34. PubMed ID: 14583467
    [Abstract] [Full Text] [Related]

  • 10. [Effects of selective cyclooxygenase-2 inhibitor on proliferation and apoptosis of human bladder cancer cell line T24].
    Zhang J, Xu ZQ, Hu Q, Qiu XW, Wang ZR.
    Ai Zheng; 2007 Apr 15; 26(4):377-81. PubMed ID: 17430655
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ.
    Clin Cancer Res; 2005 Mar 01; 11(5):1999-2007. PubMed ID: 15756026
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of cyclooxygenase (COX)-2 expression by Tet-inducible COX-2 antisense cDNA in hormone-refractory prostate cancer significantly slows tumor growth and improves efficacy of chemotherapeutic drugs.
    Dandekar DS, Lokeshwar BL.
    Clin Cancer Res; 2004 Dec 01; 10(23):8037-47. PubMed ID: 15585639
    [Abstract] [Full Text] [Related]

  • 13. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK, Joe YA, Lee SK, Kim EK, O E, Kim HK, Oh BJ, Hong SH, Hong YK.
    Cancer Lett; 2010 Feb 28; 288(2):251-60. PubMed ID: 19664879
    [Abstract] [Full Text] [Related]

  • 15. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
    Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Pasha FS, Saleem M, Mukhtar H.
    Clin Cancer Res; 2007 Mar 01; 13(5):1611-9. PubMed ID: 17332308
    [Abstract] [Full Text] [Related]

  • 16. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
    Lin J, Hsiao PW, Chiu TH, Chao JI.
    Biochem Pharmacol; 2005 Sep 01; 70(5):658-67. PubMed ID: 16004971
    [Abstract] [Full Text] [Related]

  • 17. Cyclooxygenase-2 in cancer cells and macrophages induces colon cancer cell growth by cigarette smoke extract.
    Liu ES, Shin VY, Ye YN, Luo JC, Wu WK, Cho CH.
    Eur J Pharmacol; 2005 Jul 25; 518(1):47-55. PubMed ID: 15993407
    [Abstract] [Full Text] [Related]

  • 18. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B, Shi ZL, Feng J, Tao HM.
    Cell Biol Int; 2008 May 25; 32(5):494-501. PubMed ID: 18078766
    [Abstract] [Full Text] [Related]

  • 19. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.
    Zhang L, Bertucci AM, Smith KA, Xu L, Datta SK.
    Arthritis Rheum; 2007 Dec 25; 56(12):4132-41. PubMed ID: 18050205
    [Abstract] [Full Text] [Related]

  • 20. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models.
    Williams CS, Watson AJ, Sheng H, Helou R, Shao J, DuBois RN.
    Cancer Res; 2000 Nov 01; 60(21):6045-51. PubMed ID: 11085526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.